Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WOLFSON, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WOLFSON, M.
J Am Soc Nephrol 10:2244-2247, 1999
© 1999 American Society of Nephrology

DISEASE OF THE MONTH

Management of Protein and Energy Intake in Dialysis Patients

MARSHA WOLFSON

Renal Division, Baxter HealthCare Corporation, McGaw Park, Illinois.

Correspondence to Dr. Marsha Wolfson, Renal Division Research MPR-D1, Baxter Healthcare Corporation, 1620 Waukegan Road, McGaw Park, IL 60085-6730. Phone: 847-473-6342; Fax: 847-473-6902; E-mail: wolfsonm{at}baxter.com

Abstract

Abstract. Malnutrition is not uncommon in patients with end-stage renal disease treated with maintenance dialysis. The presence of several abnormal parameters of nutritional status are reported to be predictive of poorer outcomes in these patients, compared to dialysis patients without evidence of malnutrition. This article describes methods that may be used to recognize the presence of malnutrition in end-stage renal disease patients and the management of protein and energy intake. Whether the correction of malnutrition will improve outcomes, such as morbidity and mortality, is unknown.




This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
D. Fouque, J. McKenzie, R. de Mutsert, R. Azar, D. Teta, M. Plauth, N. Cano, and the Renilon Multicentre Trial Study Group
Use of a renal-specific oral supplement by haemodialysis patients with low protein intake does not increase the need for phosphate binders and may prevent a decline in nutritional status and quality of life
Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2902 - 2910.
[Abstract] [Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673